x-1 Blog

Sanofi SA stops production of Fav-Afrique, sparking anti-dote crisis in sub-Saharan Africa

French pharmaceutical company Sanofi Pasteur says it's no longer profitable to make one of the most vital anti-venom for snakebites in Africa.Fav-Afrique counters the toxins of some of the world's most deadly venomous snakes.

Read More

Americans feel entitled to discounts on high cost medication Feature

It is well documented that the cost of prescription medication is very high in America, higher than any other region in the world. for example, Gilead's Solvadi cost $81 000 to treat Hepatitis C. As a result, patients try to do all they can to minimize the cost of medication. One of the way that patients reduce medication cost is through discounts.

Read More

Roche's Gazyva growth plans endengered after Lymphoma trial failure Feature

Roche’s Gazyva fell short in a late-stage lymphoma trial, jeopardizing the company’s expansion plans for the Rituxan follow-up. The newer med failed to best gold-standard Rituxan in previously untreated patients with diffuse large B-cell lymphoma, according to topline results from a new trial.

Read More
Trymore Magomana | magomana.com | (c) 2008 - 2016
Trymore Magomana